A detailed history of Mn Services Vermogensbeheer B.V. transactions in Incyte Corp stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 32,000 shares of INCY stock, worth $2.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,000
Previous 32,000 -0.0%
Holding current value
$2.34 Million
Previous $1.94 Million 9.02%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$56.55 - $66.59 $3.11 Million - $3.66 Million
-55,000 Reduced 63.22%
32,000 $1.82 Million
Q4 2023

Jan 29, 2024

SELL
$52.16 - $64.19 $172,128 - $211,827
-3,300 Reduced 3.65%
87,000 $5.46 Million
Q2 2023

Aug 09, 2023

SELL
$60.95 - $75.51 $146,280 - $181,224
-2,400 Reduced 2.59%
90,300 $5.62 Million
Q1 2023

Apr 26, 2023

BUY
$70.23 - $86.01 $161,529 - $197,823
2,300 Added 2.54%
92,700 $6.7 Million
Q4 2022

Feb 03, 2023

SELL
$67.18 - $84.11 $947,238 - $1.19 Million
-14,100 Reduced 13.49%
90,400 $7.26 Million
Q3 2022

Nov 01, 2022

SELL
$66.18 - $82.86 $403,698 - $505,446
-6,100 Reduced 5.52%
104,500 $6.96 Million
Q2 2022

Aug 03, 2022

BUY
$66.18 - $83.18 $7.32 Million - $9.2 Million
110,600 New
110,600 $8.4 Million
Q3 2019

Nov 12, 2019

SELL
$72.82 - $86.52 $2.38 Million - $2.83 Million
-32,751 Closed
0 $0
Q1 2019

May 06, 2019

BUY
$63.56 - $88.17 $133,476 - $185,157
2,100 Added 6.85%
32,751 $2.82 Million
Q4 2018

Feb 12, 2019

BUY
$58.5 - $69.94 $140,400 - $167,856
2,400 Added 8.5%
30,651 $1.71 Million
Q1 2018

May 11, 2018

BUY
$83.06 - $100.98 $99,672 - $121,176
1,200 Added 4.44%
28,251 $2.35 Million
Q4 2017

Feb 02, 2018

SELL
$93.56 - $116.6 $159,052 - $198,220
-1,700 Reduced 5.91%
27,051 $2.13 Million
Q3 2017

Nov 01, 2017

BUY
$109.15 - $138.27 $3.14 Million - $3.98 Million
28,751
28,751 $3.36 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mn Services Vermogensbeheer B.V. Portfolio

Follow Mn Services Vermogensbeheer B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.